<DOC>
	<DOC>NCT01250951</DOC>
	<brief_summary>This study will evaluate the efficacy and safety of deferasirox in patients with MDS, thalassemia and rare anemia patients with transfusion iron overload.</brief_summary>
	<brief_title>This Study Will Evaluate Efficacy and Safety of Deferasirox in Patients With Myelodysplastic Syndromes (MDS), Thalassemia and Rare Anemia Types Having Transfusion-induced Iron Overload.</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<mesh_term>Thalassemia</mesh_term>
	<mesh_term>Iron Overload</mesh_term>
	<mesh_term>Iron</mesh_term>
	<mesh_term>Deferasirox</mesh_term>
	<criteria>1. Age ≥ 2 years 2. Primary Diagnosis: Myelodysplastic Syndrome (presenting with low or intermediate1 IPSS risk), thalassemia or rare anemias patients (anemia DiamondBlackfan, Fanconi's anemia, Sideroblastic anemia, Red cell aplasia) 3. ECOG Performance Status ≤ 2 4. Transfusion overload confirmed with ferritin level &gt;1000 µg/l. 5. No severe concomitant uncontrolled disease (uncontrolled diabetes mellitus, heart failure, renal failure). 6. Serum creatine level &gt; ULN 7. No proteinuria 8. Liver enzymes level &lt; 5 ULN. 9. No pregnancy or lactation 10. Signed informed consent by adults. In case inclusion of children under 18 years old, the informed consent should be signed by parents. 1. Age &lt; 2 years 2. No iron overload (Ferritin level &lt;1000 µg/l). 3. Primary iron overload (hereditary hemochromatosis) 4. Severe concomitant disease (uncontrolled diabetes mellitus, heart failure, renal failure) 5. Elevated serum creatinine &gt; ULN or/and proteinuria 6. Liver enzymes level &gt;5 ULN. 7. Pregnancy or lactation. Other protocoldefined inclusion/exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Iron Overload</keyword>
	<keyword>hemotranfusion</keyword>
	<keyword>deferasirox</keyword>
	<keyword>ferritin</keyword>
	<keyword>Rare anemia</keyword>
	<keyword>Transfusional Iron Overload</keyword>
</DOC>